Acadia Pharmaceuticals Inc (ACAD)

Sales/Maturities of Investments

$494.34M

TTM · Period ending: · USD

ACAD logo

ACAD Sales/Maturities of Investments

Latest reported$494.34M
ACAD TTM Sales/Maturities of Investments ($29.85M → $494.34M)
High-resolution chart · PNG

ACAD sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Acadia Pharmaceuticals Inc Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
494,339,000
449,229,000
493,529,000
499,629,000
443,140,000
393,250,000
328,565,000
320,475,000
322,738,000
248,738,000
442,033,000
414,073,000
502,400,000
564,480,000
436,415,000
471,115,000
406,425,000
394,345,000
422,817,000
436,458,000
496,168,000
568,506,000
540,004,000
524,701,000
464,176,000
447,717,000
413,927,000
349,205,000
297,431,000
242,792,000
261,678,000
324,454,000
405,264,000
494,348,000
572,103,000
625,087,000
613,667,000
553,026,000
430,937,000
381,639,000
369,003,000
402,167,000
419,197,000
377,339,000
335,699,000
285,560,000
248,268,000
214,046,000
177,717,000
116,129,000
86,087,000
57,654,000
39,336,000
44,803,000
30,948,000
36,950,000
45,211,000
46,355,000
54,049,000
52,431,000
55,642,000
54,473,000
53,486,000
62,625,000
62,836,000
60,445,000
59,750,000
75,586,000
87,774,000
112,018,000
149,912,000
172,406,000
200,144,000
195,547,000
180,745,000
167,202,000
130,715,000
112,461,000
83,166,000
49,356,000
51,784,000
47,977,000
48,893,000
52,571,000
38,643,000
35,703,900
29,853,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.